Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

8.350 -0.250 (-2.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,965,837
Open 8.320
Bid (Size) 8.380 (1)
Ask (Size) 8.480 (9)
Prev. Close 8.600
Today's Range 8.180 - 8.735
52wk Range 4.970 - 16.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,... 
Via Talk Markets
Is Recursion Pharmaceuticals Stock a Buy?
The company is ambitious and exploring exciting areas, but it's still early in the game. 
Via The Motley Fool

Performance

YTD
-15.40%
-15.40%
1 Month
-10.89%
-10.89%
3 Month
+11.78%
+11.78%
6 Month
-18.62%
-18.62%
1 Year
-38.74%
-38.74%

More News

Read More
1 Reason to Buy Recursion Pharmaceuticals Stock and 2 Reasons to Sell
Via The Motley Fool
3 Healthcare Stocks Injecting AI for Big Gains
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Via Benzinga
These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia Is Buying Shares of These 5 AI Companies. Should You Do the Same?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
Via InvestorPlace
Why SoundHound AI Stock Lost 22% Last Month
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
Via Benzinga
Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
Via InvestorPlace
Why Recursion Pharmaceuticals Stock Is Tumbling Thursday
Via Benzinga
Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
3 AI Stocks on the Edge of a Massive Surge
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On?
Via Benzinga
Recursion Announces Proposed Offering of Class A Common Stock
From Recursion Pharmaceuticals
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening?
Via Benzinga
What's Going On With Recursion Pharmaceuticals Stock Monday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.